Sorrento Announces Clinical Research Agreement With Mayo Clinic And FDA

Sorrento Announces Clinical Research Agreement With Mayo

sorrento announces clinical research agreement with mayo clinic and fda clearance for the first phase 1b pilot study using sofusa lymphatic drug delivery technology to

Sorrento Therapeutics Sorrento Announces Clinical Research

san diego june 11 2021 globe newswire sorrento therapeutics today announced a research collaboration agreement with mayo clinic to conduct human clinical proof of